Article
Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.
Cancer genetics - 1 Dec 2016
Mukherjee Indraneil, Powell Brett, Parianos Mary, Downs Darrell, Ross Sharona B
Abstract excerpt
The incidence of pancreatic cancer, the fourth leading cause of cancer death in United States, is increasing worldwide. Even though the cure rate has doubled in 40 years, it is abysmally poor at 6-7%. As surgical resection remains the only curative treatment and less than 20% of the newly diagnosed cancers are resectable, the major burden of disease management lies in early diagnosis, good prognostication, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.